IMCC
IMCC
NASDAQ · Pharmaceuticals

Im Cannabis Corp

$3.98
+0.90 (+29.01%)
As of Sep 22, 5:31 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -11.1% upside
Low Target $2.21
Average Target $3.54
High Target $4.26
Current Price $3.98
Current
$3.98
Target
$3.54
$2.21 $3.54 avg $4.26
Scenario Analysis
Bear Case
$2.21
-44.5%
Low target
Base Case
$3.54
-11.1%
Avg target
Bull Case
$4.26
+7.0%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$3.16
25.9% from high
52-Week Low
$0.48
+737.9% from low
Target vs 52W High
$3.54
+12.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%